Imaging Biometrics Ltd (LSE:IBAI, FRA:5Y1) has published positive Phase 1 results for its oral gallium maltolate treatment in recurrent glioblastoma, with the drug found safe and well-tolerated at all dose levels. One patient has now been on treatment for more than 38 months, and the company is reactivating its Expanded Access Programme for up to 20 additional patients. Read more
Rome Resources Plc (AIM:RMR) is launching its first field programme as operator at its New Brunswick tin-tungsten-indium project in Canada this week, with more than 500 samples planned across three priority targets. The company will spend up to CA$150,000 before deciding whether to exercise its option to acquire working interests in the licences. Read more
London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) has staked its first US gold project, securing 111 mineral claims covering 2,293 acres in Nevada's Humboldt County. Surface sampling is already underway, with assay results expected by mid-June and further staking in Nevada and Arizona being advanced in parallel. Read more
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF, FRA:VD5N) has cleared a key hurdle at its Paradox project in Utah after a pipeline inspection confirmed no repairs are needed and the formal regulatory approval process can now begin. CEO Colin Harrington says the result allows the company to finalise offtake agreements and advance its farm-out process. Read more
Silver Bullet Data Services Group PLC (AIM:SBDS) shares crashed 60% to 10p after the marketing technology company announced plans to delist from AIM. The board says public market conditions no longer reflect the company's value and that private ownership would better support future funding, with shareholders asked to approve the move at a general meeting on 25 June. Read more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.